文献速递胸部肿瘤放疗放疗物理与技术

特发性肺纤维化:当前认识、未来展望及其在放射肿瘤学中的重要性

Idiopathic pulmonary fibrosis: Current knowledge, future perspectives and its importance in radiation oncology.
PubMed 文献 · Radiother Oncol · 2020-11-24

本文综述特发性肺纤维化(IPF)的发病机制与预后现状,指出IPF是胸部放疗后肺毒性的重要风险因素,可增加严重及致死性并发症风险;质子束治疗显示降低危及生命并发症的潜力但证据尚不足以推荐标准使用;IPF与放射性肺损伤(RILI)在发病机制上存在相似性。

要点

  • IPF是胸部放疗后肺毒性的重要风险因素,可增加严重和致死性并发症风险。
  • 目前IPF尚未被普遍接受为胸部放疗的绝对禁忌证。
  • 质子束治疗在减少IPF患者胸部放疗危及生命并发症方面显示前景,但证据不足推荐标准使用。

核心结论

  • IPF是胸部放疗后肺毒性的关键风险因素,可增加严重和致死性并发症风险,需在放射肿瘤学实践中重视。
  • IPF与RILI在发病机制和潜在机制上存在许多相似之处,深入理解两者机制有助于为IPF癌症患者提供更安全有效的胸部放疗。

研究设计与样本

  • 本文为综述,总结IPF的当前认识、其在放射肿瘤学实践中的重要性以及IPF与RILI的相似性和关系。

主要发现

  • IPF是一种病因不明的进行性纤维化肺病,尽管近期治疗有所改善,但预后仍差。
  • RILI是胸部放疗的常见并发症和剂量限制性毒性。
  • IPF可增加胸部放疗后严重和致死性并发症的风险。
  • 质子束治疗在降低IPF患者胸部放疗相关危及生命并发症发生率方面显示有希望的结果,但当前证据不足以推荐其标准使用。

临床怎么用

  • 对合并IPF的癌症患者行胸部放疗时,应充分评估肺毒性风险,警惕严重和致死性并发症。
  • 质子束治疗可作为降低IPF患者胸部放疗危及生命并发症的潜在选择,但尚不能作为标准推荐。

局限性

  • 当前质子束治疗用于IPF患者的证据不足以推荐标准使用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Idiopathic pulmonary fibrosis (IPF) is a progressive, fibrotic lung disease with an unknown cause. Uncertainties still remain regarding the pathogenesis of IPF, and the prognosis of this disease is poor despite some recent improvements in treatment. Radiation induced lung injury (RILI) is a common complication and a dose-limiting toxicity of thoracic radiotherapy. Importantly, IPF is a crucial risk factor for pulmonary toxicity after thoracic radiotherapy. Although IPF is not universally accepted as a definite contraindication for thoracic radiotherapy at present, it has been shown that IPF can increase the risk of severe and fatal complications after thoracic radiotherapy. Proton beam therapy has shown promising results in reducing the incidence of thoracic radiotherapy related life-threatening complications in IPF patients, but the current evidence is not sufficient to recommend the standard use of it. Many similarities are noticeable between IPF and RILI in terms of pathogenesis and underlying mechanisms. Better understanding of the mechanisms of IPF and RILI may enable clinicians to provide safer and more effective thoracic radiotherapy treatments in cancer patients with IPF. In this review, we summarize the current knowledge of IPF, present the importance of IPF in radiation oncology practice, and highlight the similarities and relationship between IPF and RILI.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Türkkan G, Willems Y, Hendriks LEL, et al. Idiopathic pulmonary fibrosis: Current knowledge, future perspectives and its importance in radiation oncology. Radiother Oncol. 2020. PMID: 33245945. doi:10.1016/j.radonc.2020.11.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。